Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr738 Inhibitors

Olfr738, encoded by the Or11g1 gene in house mice, is part of the olfactory receptor family, a group of G-protein-coupled receptors (GPCRs) responsible for detecting odorants and initiating neuronal responses that lead to the perception of smell. These receptors have a characteristic 7-transmembrane domain structure and function through the recognition and transduction of odorant signals via G protein activation. This activation triggers a cascade of intracellular signaling events, primarily involving the production of secondary messengers like cyclic AMP (cAMP). The inhibition of Olfr738, and olfactory receptors in general, involves understanding their complex signaling pathways and the broader neurochemical environment in which they operate. As GPCRs, these receptors are influenced by the levels and interactions of various neurotransmitters and their respective receptors. Indirect inhibition can occur through several mechanisms. One primary route is the modulation of cAMP levels, a key secondary messenger in GPCR signaling. Compounds that influence the production or degradation of cAMP can, therefore, have an indirect impact on the signaling of olfactory receptors. This is because the activation and function of these receptors often depend on the cellular concentration of cAMP, which in turn regulates various downstream processes.

Another indirect method of inhibition involves the modulation of neurotransmitter systems. This includes the use of antagonists for adrenergic, dopaminergic, or serotonergic receptors. By influencing these neurotransmitter systems, it is possible to indirectly affect the functioning of olfactory receptors. Changes in neurotransmitter levels or receptor dynamics can alter the overall signaling environment in which GPCRs operate, potentially modifying their activity. In summary, the inhibition of Olfr738, a GPCR in the olfactory system, can potentially be achieved indirectly by targeting the key components of its signaling pathways. This includes manipulating cAMP levels or modulating various neurotransmitter systems. Understanding these pathways and their interconnections is crucial for exploring how to influence the function of olfactory receptors like Olfr738 indirectly.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol is a beta-adrenergic antagonist that decreases cAMP levels, a secondary messenger in GPCR signaling. Reduced cAMP may indirectly affect Olfr738 signaling, as cAMP is crucial in olfactory receptor transduction processes.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$122.00
$235.00
$520.00
$979.00
$1500.00
2
(1)

Carvedilol, a beta-blocker with alpha-1 blocking activity, can lower cAMP levels by inhibiting adrenergic receptors. This could indirectly influence Olfr738 signaling pathways due to the role of cAMP in GPCR-mediated olfactory transduction.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$50.00
$168.00
$520.00
2
(1)

As an alpha-2 adrenergic antagonist, Yohimbine increases neurotransmitter release, possibly affecting GPCR signaling, including Olfr738 pathways, by modifying the neurotransmitter balance and receptor interactions.

Ketanserin

74050-98-9sc-279249
1 g
$700.00
(0)

Ketanserin, a 5-HT2A serotonin receptor antagonist, alters serotonin signaling, potentially affecting Olfr738 indirectly due to the role of serotonin in modulating GPCR pathways.

Clozapine

5786-21-0sc-200402
sc-200402A
50 mg
500 mg
$68.00
$357.00
11
(1)

Clozapine, an atypical antipsychotic, affects multiple neurotransmitter systems. This broad action could indirectly impact Olfr738 signaling by altering neurotransmitter levels and receptor dynamics.

Haloperidol

52-86-8sc-507512
5 g
$190.00
(0)

As a dopamine antagonist, Haloperidol influences dopaminergic pathways, which could indirectly affect Olfr738 signaling by modulating dopaminergic activity and receptor interactions.

Risperidone

106266-06-2sc-204881
sc-204881A
sc-204881B
sc-204881C
10 mg
50 mg
1 g
5 g
$171.00
$705.00
$1000.00
$2000.00
1
(1)

Risperidone, acting on both dopamine and serotonin receptors, could indirectly impact Olfr738 signaling by affecting neurotransmitter systems and GPCR-mediated pathways.

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$80.00
$326.00
1
(0)

Ondansetron, a 5-HT3 receptor antagonist, could indirectly affect Olfr738 by altering serotonin signaling, which is integral to GPCR-mediated pathways in olfactory transduction.

(RS)-Atenolol

29122-68-7sc-204895
sc-204895A
1 g
10 g
$77.00
$408.00
1
(1)

Atenolol, a selective beta1-adrenergic antagonist, could influence Olfr738 indirectly by modulating adrenergic activity and cAMP levels, crucial in GPCR signaling.

Metoprolol Tartrate

56392-17-7sc-205751
sc-205751A
5 g
25 g
$105.00
$238.00
3
(1)

By selectively blocking beta1-adrenergic receptors, Metoprolol could indirectly affect Olfr738 signaling pathways through alterations in cAMP levels and adrenergic signaling.